Dr Gil Morgan from OncoAlert gives his oncology highlights from social media for the week of April 19 - 25, 2021.

Alerts this week cover papers from New England, Lancet Oncology, BMC Cancer, The Oncologist, Nature Medicine, and JAMA Oncology.

Dr Morgan also highlights the success of the sacituzumab govitecan trial in patients with pre-treated metastatic triple negative breast cancer.

You can watch Dr Morgan's previous roundup here.

Follow Dr Morgan on twitter: @OncoAlert

Follow ecancer on twitter: @ecancer